| ADAM9 | A disintegrin and a metalloprotease 9 |
| ArgBP2 | Sorbin and SH3 domain-containing protein 2 |
| AIPC | Androgen-independent prostate cancer |
| APP | Amyloid-precursor-protein |
| CDCP1 | CUB domain containing protein 1 |
| COPD | Chronic obstructive pulmonary disease |
| CRD | Cone-rod dystrophy |
| ECM | Extracellular matrix |
| EGF | Epidermal growth factor |
| EMCV | Encephalomyocarditis virus |
| EMT | Epithelial-mesenchymal transition |
| EphB4 | Ephrin type-B receptor 4 |
| GBM | Glioblastoma |
| HB-EGF | Heparin-binding EGF-like growth factor |
| HCC | Hepatocellular carcinoma |
| HVR | Hyper-variable region |
| MDC9 | Metalloprotease/disintegrin/cysteine-rich protein 9 |
| MGCs | Multinucleated giant cells |
| MICA | MHC Class I polypeptide-related sequence A |
| MiRNA | microRNA |
| MMP | Matrix metalloproteinase |
| Naa10p | N-α-Acetyltransferase 10 protein |
| PC | Proprotein convertase |
| PMNs | Polymorphonuclear neutrophils |
| PrPc | Cellular prion protein |
| SH3 | Src-homology 3 |
| SNX | Sorting nexin |
| TNBC | Triple-negative breast cancer |
| TNC | Tenascin-C |
| TNF-α | Tumor necrosis factor-α |
| tPA | Tissue-type plasminogen activator |
| VE-cadherin | Vascular endothelial cadherin |